Clinical trials
Terminated Observational Heart Defects, Congenital trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Healthcare of Atlanta | 7 |
| Emory University | 7 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Artivion Inc. | 1 |
| Aymen N Naguib | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Seoul National University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Defects, Congenital | 24 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 3 |
| Heart Failure | 2 |
| Acute Coronary Syndrome | 1 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Cyanosis | 1 |
| DiGeorge Syndrome | 1 |
| Heart Neoplasms | 1 |
| Heart Septal Defects, Ventricular | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.